Parkinson's pump study tracks Real-Life symptom control

NCT ID NCT07219927

Recruiting now Symptom relief Sponsor: Supernus Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 120 people with Parkinson's disease who are using a continuous apomorphine infusion pump (ONAPGO™) to see how it works in real-world settings. Researchers will track how long it takes to find the right dose, any changes to other Parkinson's medications, and how patients feel their overall health has changed. The goal is to understand the practical benefits and challenges of this treatment outside of a controlled clinic environment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE

Contacts and locations

Locations

Parkinson's Disease & Movement Disorders Center of Boca Raton
RECRUITING

Boca Raton, Florida, 33486, United States
Parkinson's Disease and Movement Disorders Center - Long Island
RECRUITING

Commack, New York, 11725, United States
Parkinson's Disease and Movement Disorders Center - Orange County (North)
RECRUITING

Irvine, California, 92618, United States
Parkinson's Disease and Movement Disorders Center - Orange County (South)
RECRUITING

Aliso Viejo, California, 92656, United States
Parkinson's Research Centers of America - Palo Alto
RECRUITING

Palo Alto, California, 94301, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.